Schonfeld Strategic Advisors LLC lifted its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 291.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,471 shares of the medical technology company's stock after buying an additional 13,755 shares during the quarter. Schonfeld Strategic Advisors LLC's holdings in Teleflex were worth $3,287,000 at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in the stock. Headlands Technologies LLC acquired a new position in shares of Teleflex in the fourth quarter valued at $29,000. Avior Wealth Management LLC lifted its position in Teleflex by 81.2% in the 4th quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock valued at $50,000 after acquiring an additional 125 shares in the last quarter. IFP Advisors Inc increased its position in shares of Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock valued at $55,000 after acquiring an additional 217 shares during the last quarter. Exchange Traded Concepts LLC lifted its holdings in Teleflex by 38.2% during the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after purchasing an additional 94 shares during the last quarter. Finally, R Squared Ltd purchased a new position in Teleflex during the fourth quarter worth about $64,000. 95.62% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of brokerages recently issued reports on TFX. Piper Sandler reiterated a "neutral" rating and issued a $140.00 price target (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Bank of America lowered shares of Teleflex from a "neutral" rating to an "underperform" rating and reduced their target price for the stock from $235.00 to $140.00 in a research report on Tuesday, March 4th. StockNews.com downgraded shares of Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Truist Financial dropped their price objective on shares of Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a research note on Monday. Finally, Wells Fargo & Company decreased their target price on shares of Teleflex from $146.00 to $137.00 and set an "equal weight" rating for the company in a research note on Friday, May 2nd. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, Teleflex has an average rating of "Hold" and an average target price of $164.63.
View Our Latest Analysis on Teleflex
Teleflex Price Performance
NYSE:TFX traded up $1.83 during trading hours on Wednesday, hitting $122.40. 521,196 shares of the stock were exchanged, compared to its average volume of 637,766. The company has a market cap of $5.68 billion, a P/E ratio of 24.33, a P/E/G ratio of 1.73 and a beta of 1.17. The firm's fifty day moving average price is $134.36 and its 200 day moving average price is $168.73. Teleflex Incorporated has a 52-week low of $114.80 and a 52-week high of $249.91. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.
Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company had revenue of $700.67 million for the quarter, compared to analyst estimates of $699.37 million. During the same quarter last year, the firm posted $3.21 EPS. The firm's revenue for the quarter was down 5.0% on a year-over-year basis. As a group, equities research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.
Teleflex Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.11%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex's payout ratio is currently 42.90%.
About Teleflex
(
Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
See Also

Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.